Literature DB >> 15699042

Structures of Escherichia coli NAD synthetase with substrates and products reveal mechanistic rearrangements.

Ralf Jauch1, Andreas Humm, Robert Huber, Markus C Wahl.   

Abstract

Nicotinamide adenine dinucleotide synthetases (NADS) catalyze the amidation of nicotinic acid adenine dinucleotide (NAAD) to yield the enzyme cofactor nicotinamide adenine dinucleotide (NAD). Here we describe the crystal structures of the ammonia-dependent homodimeric NADS from Escherichia coli alone and in complex with natural substrates and with the reaction product NAD. The structures disclosed two NAAD/NAD binding sites at the dimer interface and an adenosine triphosphate (ATP) binding site within each subunit. Comparison with the Bacillus subtilis NADS showed pronounced chemical differences in the NAAD/NAD binding sites and less prominent differences in the ATP binding pockets. In addition, the E. coli NADS structures revealed unexpected dynamical rearrangements in the NAAD/NAD binding pocket upon NAAD-to-NAD conversion, which define a catalysis state and a substrate/product exchange state. The two states are adopted by concerted movement of the nicotinysyl moieties of NAAD and NAD, Phe-170, and residues 224-228, which may be triggered by differential coordination of a magnesium ion to NAAD and NAD. Phylogenetic structure comparisons suggest that the present results are relevant for designing species-specific antibiotics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699042     DOI: 10.1074/jbc.M413195200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Regulation of active site coupling in glutamine-dependent NAD(+) synthetase.

Authors:  Nicole LaRonde-LeBlanc; Melissa Resto; Barbara Gerratana
Journal:  Nat Struct Mol Biol       Date:  2009-03-08       Impact factor: 15.369

2.  Streptococcus pyogenes quinolinate-salvage pathway-structural and functional studies of quinolinate phosphoribosyl transferase and NH3 -dependent NAD+ synthetase.

Authors:  William T Booth; Trevor L Morris; David P Mysona; Milan J Shah; Linda K Taylor; Taylor W Karlin; Kathryn Clary; Karolina A Majorek; Lesa R Offermann; Maksymilian Chruszcz
Journal:  FEBS J       Date:  2017-07-07       Impact factor: 5.542

3.  Cloning, expression, purification, crystallization and preliminary X-ray diffraction studies of NAD synthetase from methicillin-resistant Staphylococcus aureus.

Authors:  Gajanan Kashinathrao Arbade; Sandeep Kumar Srivastava
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-05-22       Impact factor: 1.056

4.  Kinetics and structural features of dimeric glutamine-dependent bacterial NAD+ synthetases suggest evolutionary adaptation to available metabolites.

Authors:  Adrian Richard Schenberger Santos; Edileusa Cristina Marques Gerhardt; Vivian Rotuno Moure; Fábio Oliveira Pedrosa; Emanuel Maltempi Souza; Riccardo Diamanti; Martin Högbom; Luciano Fernandes Huergo
Journal:  J Biol Chem       Date:  2018-03-26       Impact factor: 5.157

5.  Biogenesis and Homeostasis of Nicotinamide Adenine Dinucleotide Cofactor.

Authors:  Andrei Osterman
Journal:  EcoSal Plus       Date:  2009-08

6.  Glutamine versus ammonia utilization in the NAD synthetase family.

Authors:  Jessica De Ingeniis; Marat D Kazanov; Konstantin Shatalin; Mikhail S Gelfand; Andrei L Osterman; Leonardo Sorci
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

7.  Impairment of NADH dehydrogenase and regulation of anaerobic metabolism by the small RNA RyhB and NadE for improved biohydrogen production in Enterobacter aerogenes.

Authors:  Yan Wu; Yaqiao Hao; Xuan Wei; Qi Shen; Xuanwei Ding; Liyan Wang; Hongxin Zhao; Yuan Lu
Journal:  Biotechnol Biofuels       Date:  2017-10-30       Impact factor: 6.040

8.  Different ways to transport ammonia in human and Mycobacterium tuberculosis NAD+ synthetases.

Authors:  Watchalee Chuenchor; Tzanko I Doukov; Kai-Ti Chang; Melissa Resto; Chang-Soo Yun; Barbara Gerratana
Journal:  Nat Commun       Date:  2020-01-07       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.